Xenetic Biosciences, Inc. – NASDAQ:XBIOW
Xenetic Biosciences stock price today
Xenetic Biosciences stock price monthly change
Xenetic Biosciences stock price quarterly change
Xenetic Biosciences stock price yearly change
Xenetic Biosciences key metrics
Market Cap | 26.96M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -2.92 |
Revenue | 2.44M |
EBITDA | -4.86M |
Income | -4.47M |
Revenue Q/Q | -15.68% |
Revenue Y/Y | 27.09% |
Profit margin | -754.79% |
Oper. margin | -767.58% |
Gross margin | 0% |
EBIT margin | -767.58% |
EBITDA margin | -199.14% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeXenetic Biosciences stock price history
Xenetic Biosciences stock forecast
Xenetic Biosciences financial statements
| Jun 2023 | 651.00K | -1.05M | -161.44% |
|---|---|---|---|
| Sep 2023 | 611.17K | -1.05M | -172.71% |
| Dec 2023 | 671.96K | -1.17M | -174.34% |
| Mar 2024 | 510.81K | -1.19M | -233.96% |
| Jun 2023 | 12749173 | 871.31K | 6.83% |
|---|---|---|---|
| Sep 2023 | 11961066 | 1.06M | 8.93% |
| Dec 2023 | 10605226 | 809.58K | 7.63% |
| Mar 2024 | 9394096 | 716.49K | 7.63% |
| Jun 2023 | -1.26M | 0 | 0 |
|---|---|---|---|
| Sep 2023 | -949.63K | 0 | 0 |
| Dec 2023 | -793.02K | 0 | 0 |
| Mar 2024 | -1.15M | 0 | 0 |
Xenetic Biosciences alternative data
| Jan 2024 | 4 |
|---|---|
| Feb 2024 | 4 |
| Mar 2024 | 4 |
| Apr 2024 | 4 |
| May 2024 | 4 |
| Jun 2024 | 4 |
| Jul 2024 | 4 |
Xenetic Biosciences other data
-
What's the price of Xenetic Biosciences stock today?
One share of Xenetic Biosciences stock can currently be purchased for approximately $17.54.
-
When is Xenetic Biosciences's next earnings date?
Unfortunately, Xenetic Biosciences's (XBIOW) next earnings date is currently unknown.
-
Does Xenetic Biosciences pay dividends?
No, Xenetic Biosciences does not pay dividends.
-
How much money does Xenetic Biosciences make?
Xenetic Biosciences has a market capitalization of 26.96M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 48.8% to 2.54M US dollars.
-
What is Xenetic Biosciences's stock symbol?
Xenetic Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "XBIOW".
-
What is Xenetic Biosciences's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Xenetic Biosciences?
Shares of Xenetic Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Xenetic Biosciences have?
As Jul 2024, Xenetic Biosciences employs 4 workers.
-
When Xenetic Biosciences went public?
Xenetic Biosciences, Inc. is publicly traded company for more then 6 years since IPO on 23 Jul 2019.
Xenetic Biosciences company profile:
NASDAQ
4
Biotechnology
Healthcare
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
,
CIK: 0001534525
:
CUSIP: 984015131
